Skin lesions in endocrine diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Endocrine diseases are accompanied by diverse skin manifestations, which can vary from general signs such as acne, hirsutism, hyper- or hypopigmentation, to extremely rare dermatoses. These symptoms can significantly affect the quality of life of patients. This article presents the most common skin lesions in different endocrinopathies: disorders of the thyroid gland, hypothalamic-pituitary axis, pancreas, adrenal glands, androgenic axis, as well as hereditary endocrine syndromes. Skin manifestations can be the first and isolated signs of the development of endocrine pathology; therefore, doctors of various specialties, namely dermatologists and therapists, need to know the skin symptoms of endocrine disorders for prompt diagnosis and determination of the optimal patient management tactics in cooperation with an endocrinologist.

Full Text

Restricted Access

About the authors

Daria O. Ladygina

Central State Medical Academy of Department of Presidential Affairs

Email: ladygina.do@gmail.com
Cand. Sci (Med.), Head of the Department of Endocrinology

A. V Zheleznyakova

National Medical Research Center of Endocrinology

L. S Kruglova

Central State Medical Academy of Department of Presidential Affairs

References

  1. Трухан Д.И., Викторова И.А., Багишева Н.В. Изменения кожи при соматических заболеваниях. Международный журнал при -кладных и фундаментальных исследований. 2016;8-5:736-40.
  2. Raj R., Elshimy G., Mishra R., et ai. Dermatologic Manifestations of Endocrine Disorders. Cureus. 2021;13(9):e18327. Doi: 10.7759/ cureus.18327.
  3. Рузиева С.Х. Дерматологические проявления эндокринных заболеваний. Вестник современных исследований. 2018;6.1(21):85-90.
  4. Трошина Е.А. Поражения кожи при заболеваниях щитовидной железы и синдромах, включающих тиреоидную патологию. Consilium Medicum. 2020;22(7):60-3. Doi: 10. 26442/20751753.2020.7.200289.
  5. Фадеев В.В. По материалам клинических рекомендаций Европейской тиреоидной ассоциации по диагностике и лечению тиреотоксикоза при болезни Грейвса 2018 года. Клиническая и экспериментальная тиреоидология. 2020;16(1):4-20. doi: 10.14341/ ket12474.
  6. Safer J.D. Thyroid hormone action on skin. Dermatoendocrinol. 2011;3:211-15. doi: 10.4161/derm.3.3.17027.
  7. Lause M., Kamboj A., Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017;6(4):300-12. doi: 10.21037/tp.2017.09.08.
  8. Fatourechi V., Ahmed D.D., Schwartz K.M. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J. Clin Endocrinol Metab 2002;87(12):5435-41. doi: 10.1210/ jc.2002-020746.
  9. Фадеев В.В. Современные принципы диагностики и лечения гипотиреоза. Медицинский совет. 2013;4-2:76-81.
  10. Mancino G., Miro C., Di Cicco E., Dentice M. Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin. J. Endocrinol. Invest. 2021;44(8):1571-79. doi: 10.1007/s40618- 020-01492-2.
  11. Качук Ю.В. Поражение кожи при нарушениях функции щитовидной железы. Дерматовенерология. Косметология. Сексопатология. 2013;1-4:228-32.
  12. Higham C.E., Johannsson G., Shalet S.M. Hypopituitarism. Lancet. 2016;388:2403-15. doi: 10.1016/S0140-6736(16)30053-8.
  13. Theoharides T.C., Stewart J.M., Taracanova A., etal. Neuroendocrinology of the skin. Rev Endocr Metab Disord. 2016;17(3):287-94. Doi: 10.1007/ s11154-016-9369-9.
  14. Demirkesen C. Skin Manifestations of Endocrine Diseases. Turk Patol Derg. 2015;31(Suppl. 1):145-54. doi: 10.5146/tjpath.2015.01321.
  15. Дедов И.И., Молитвословова Н.Н., Рожинская Л.Я., Мельниченко ГА. Федеральные клинические рекомендации по клинике, диагностике, дифференциальной диагностике и методам лечения акромегалии. Проблемы эндокринологии. 2013;59(6):4-18.
  16. Ben-Shlomo A., Melmed S. Skin manifestations in acromegaly. Clin Dermatol. 2006;24(4):256-59. doi: 10.1016/j.clindermatol.2006.04.011.
  17. Sandru F, Popa A., Paduraru D.N., et al. Skinanomalies in acromegalic patients (Review of the practical aspects). Exp Ther Med. 2021;22(5):1330. doi: 10.3892/etm.2021.10765.
  18. Degirmentepe E.N., Gungor S., Kocaturk E., et al. Dermatologic manifestations of acromegaly: A case in point and a focused review. Dermatol. On-line J. 2017;23(8):13030/qt50s903qh.
  19. John A.M., Schwartz R.A. Glucagonoma syndrome: a review and update on treatment. J. Eur. Acad. Dermatol. Venereol. 2016;30:2016-22. doi: 10.1111/jdv.13752.
  20. Jabbour S.A. Skin manifestations of hormone-secreting tumors. Dermatol Ther. 2010;23(6):643-50. doi: 10.1111/j.1529-8019.2010.01369.x.
  21. Тлиш М.М., Глузмин М.И., Кузнецова Т.Г. Некролитическая эритема: казуистика? Вестник дерматологии и венерологии. 2011;6:73-6.
  22. Rosen J., Yosipovitch G. Skin Manifestations of Diabetes Mellitus. In: Feingold K.R., Anawalt B., Boyce A., et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; January 4, 2018.
  23. Mendes A.L., Miot H.A., Haddad V. Diabetes mellitus and the skin. An Bras Dermatol. 2017;92(1):8-20. doi: 10.1590/abd1806-4841.20175514.
  24. Lacroix A., Feelders R.A., Stratakis C.A., Nieman L.K. Cushing’s syndrome. Lancet. 2015;386(9996):913-27. Doi: 10.1016/ s0140-6736(14)61375-1.
  25. Jabbour S.A. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J. Clin Dermatol. 2003;4(5):315-31. doi: 10.2165/00128071-200304050-00003.
  26. Quatrano N.A., loechner K.J. Dermatologic manifestations of endocrine disorders. Curr Opin Pediatr. 2012;24(4):487-93. Doi: 10.1097/ MOP.0b013e328355a31b.
  27. Mirza F.N., Leventhal J.S. The rash in life-threatening metabolic and endocrine disorders. Clin Dermatol. 2020;38(1):79-85. Doi: 10.1016/j. clindermatol.2019.10.018.
  28. Feingold K.R., Elias P.M. Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous disorders. J. Am Acad Dermatol. 1988; 19(1 Pt. 1):1-20.
  29. Hafsi W., Badri T. Hirsutism. 2021 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 29262139.
  30. Saric-Bosanac S., Clark A.K., Sivamani R.K., Shi VY The role of hypothalamus-pituitary-adrenal (HPA)-like axis in inflammatory pilosebaceous disorders. Dermatol. On-line J. 2020;26(2):13030/ qt8949296f.
  31. Stratakis C.A. Hereditary syndromes predisposing to endocrine tumors and their skin manifestations. Rev Endocr Metab Disord. 2016;17:381-88. doi: 10.1007/s11154-016-9401-0
  32. Laat J.M., van der Luijt R.B., Pieterman C.R., et al.: MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC. Med. 2016;14:182. doi: 10.1186/s12916-016-0708-1.
  33. Scapineli J.O., Ceolin L., Pun ales M.K., et al. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics. Fam Cancer. 2016;15:625-33. Doi: 10.1007/ s10689-016-9892-6.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies